Device / Technology News

RSS

Illumina launches new RNA sequencing kits

Illumina today introduced TruSeq Stranded mRNA and Total RNA Sample Preparation Kits for RNA sequencing. The new reagent kits enable researchers to quickly and easily conduct gene expression studies that provide a complete view of the transcriptome, even from low-quality RNA samples, such as formalin-fixed, paraffin-embedded (FFPE) samples.

From Illumina, Inc. 19 Sep 2012

U-Systems receives FDA approval for somo-v ABUS

The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.

19 Sep 2012

Pediatric clearance for K2M’s treatment of adolescent idiopathic scoliosis

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that it has received an additional clearance to treat adolescent idiopathic scoliosis.

18 Sep 2012

EmbryoScope Time-lapse system identifies abnormal development events in embryos

Which embryos have the best opportunity to develop into a viable pregnancy? A new technology provides a surprising answer. A major challenge in the field of IVF is selecting the single best embryo which is likely to result in a live birth. Currently, embryologists must remove the embryo from a standard incubator to perform 2 or 3 short evaluations of the developing embryo under the microscope, at fixed time-points over 3-5 days, in order to assess embryo quality prior to transferring an embryo to the patient.

18 Sep 2012

ChanTest announces Phase II SBIR grant to optimize cardiomyocyte-based assays

ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes

18 Sep 2012

No link between low-level electromagnetic field exposure from mobile phones and health risks

There is no scientific evidence that low-level electromagnetic field exposure from mobile phones and other transmitting devices causes adverse health effects, according to a report presented by a Norwegian Expert Committee. In addition, the Committee provides advice to authorities about risk management and regulatory practice.

18 Sep 2012

ProImmune launches ProStorm in vitro cytokine release assay

ProImmune Ltd., a leader in services for understanding immune responses, announced today the commercial launch of ProStorm, an in vitro cytokine release assay, which can help assess the likelihood of first infusion reactions to novel therapeutics.

18 Sep 2012

Covidien now offers unique solutions for treatment of chronic total occlusions

Covidien, a leading global provider of healthcare products, today announced the launch of the Viance Crossing Catheter and Enteer Re-entry System for treating chronic total occlusions (CTOs) endovascularly.

18 Sep 2012

Fall prediction and prevention technology: an interview with Rob Goudswaard and Heribert Baldus from Philips

Falls in the elderly are a major health problem. It is has emerged from data in the US that roughly 1 in 3 people over 65 fall at least once a year. Half of them experience the same again the next year.

18 Sep 2012

Community Hospital Grand Junction chooses SIS Solution to replace legacy perioperative system

Surgical Information Systems (SIS), a leader in perioperative information systems, announced today that Community Hospital Grand Junction has selected the SIS Solution to replace its legacy perioperative system.

18 Sep 2012

New light-based technique demonstrates that toxic proteins build up gradually in blood cells

A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.

18 Sep 2012

EMD Millipore announces global licensing agreement for AJ's iPS cell patent portfolio

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and iPS Academia Japan, Inc. today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.

18 Sep 2012

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.

18 Sep 2012

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.

17 Sep 2012

MediSapiens launches unified cloud computing application for personalized genomics

MediSapiens launches first-in-kind fully integrated and unified cloud computing application that harnesses the power of Big Data and enables knowledge-based drug discovery and repositioning for personalized genomics.

17 Sep 2012

New test to assess viral load of cytomegalovirus

Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.

From Roche Sequencing and Life Science 17 Sep 2012

Medicare upcoding could be adding to health care costs

The Center for Public Integrity reports on a trend in which many physicians and other medical professionals are billing Medicare for complicated and costly care. Some say this pattern signals an increase in medical billing abuse while others maintain it reflects seniors' need for more complex care.

17 Sep 2012

Mobile phone text messaging service allows health workers to track malaria cases in Cambodia

A new pilot project in Cambodia is allowing more than 3,000 volunteer health workers to use a special mobile phone text messaging service to report new cases of malaria, in addition to providing no-cost testing and treatment "in remote parts of the impoverished nation, where access to health services can be difficult," Agence France-Presse reports.

17 Sep 2012

Breath testing could discriminate between benign and malignant pulmonary nodules

A pilot study, published in the October 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed that breath testing could be used to discriminate between benign and malignant pulmonary nodules.

17 Sep 2012

Bruker introduces new solariX XR Fourier Transform Mass Spectrometer with ParaCell

At the 19th International Mass Spectrometry Conference, Bruker today introduced the breakthrough new solariX XR Fourier Transform Mass Spectrometer (FTMS) with the revolutionary ParaCell for extreme mass resolution greater than 10 million.

17 Sep 2012

Device / Technology News

Illumina launches new RNA sequencing kits

U-Systems receives FDA approval for somo-v ABUS

Pediatric clearance for K2M’s treatment of adolescent idiopathic scoliosis

EmbryoScope Time-lapse system identifies abnormal development events in embryos

ChanTest announces Phase II SBIR grant to optimize cardiomyocyte-based assays

No link between low-level electromagnetic field exposure from mobile phones and health risks

ProImmune launches ProStorm in vitro cytokine release assay

Covidien now offers unique solutions for treatment of chronic total occlusions

Fall prediction and prevention technology: an interview with Rob Goudswaard and Heribert Baldus from Philips

Community Hospital Grand Junction chooses SIS Solution to replace legacy perioperative system

New light-based technique demonstrates that toxic proteins build up gradually in blood cells

EMD Millipore announces global licensing agreement for AJ's iPS cell patent portfolio

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

MediSapiens launches unified cloud computing application for personalized genomics

New test to assess viral load of cytomegalovirus

Medicare upcoding could be adding to health care costs

Mobile phone text messaging service allows health workers to track malaria cases in Cambodia

Breath testing could discriminate between benign and malignant pulmonary nodules

Bruker introduces new solariX XR Fourier Transform Mass Spectrometer with ParaCell

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News